33.98MMarket Cap-8529P/E (TTM)
4.350High4.130Low8.45KVolume4.130Open4.250Pre Close35.86KTurnover0.16%Turnover RatioLossP/E (Static)7.81MShares5.88052wk High1.38P/B23.02MFloat Cap4.06052wk Low--Dividend TTM5.29MShs Float13.200Historical High--Div YieldTTM5.18%Amplitude1.000Historical Low4.245Avg Price1Lot Size
ImmuCell Stock Forum
ImmuCell Corporation (Nasdaq: ICCC), a key player in the animal health industry, has recently announced its preliminary, unaudited sales results for the first quarter of 2024, and the figures are nothing short of impressive. With a staggering 111% increase in sales compared to the same period in 2023, and a 42% increase from the last quarter of ...
No comment yet